Navigation Links
Australian Scientists Develop Novel Drug To Combat Inflammatory Diseases

Researchers from Garvan Institute of Medical Research, Sydney have expressed hope over their newly developed drug to combat a severe inflammatory disease, rheumatoid arthritis. //It is also claimed to improve the clinical outcome in patients with asthma, multiple sclerosis, heart attack, sepsis, psoriasis and post transplant recipients.

The unique drug formulation has been tested on animal models (mice) and promising results have been obtained. It has been found to provide a dramatic pain reduction. In addition, it also promoted the general health status of the sufferer.

The identification of a specific mechanism by which the circulating while blood cells release toxic substances into the joints, causing joint damage is said to have triggered the discovery. Following injection of the new drug, the diseased tissue is restored back to the normal state within hours.

The ability of the drug to reverse the disease process in affected mice is remarkable. The development of this drug is believed to be a major milestone in the treatment of rheumatoid arthritis. The researchers have however warned that this prospective drug treatment cannot be considered a cure as the disease can relapse sometime later.

The researchers are now eagerly looking forward to conducting an extensive human clinical trial in volunteers to determine the safety and efficacy of the drug. This proposal is expected to be materialized in the next 18 months.


'"/>




Page: 1

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
3. Australian Company Gets $10 million For Developing Skin Cancer Gel
4. Australian Health funds stand accused
5. Australian Court Finds Man Guilty of Spreading HIV/AIDS
6. Sale Of Bird Flu Vaccine to US Planned: Australian Firm
7. Hepatitis C Could Infect 800,000 Australians By 2020
8. Obesity Cost More Than The Australian Health Budget
9. Australian Snake Venom Can Arrest Bleeding During Surgery And Trauma
10. Fat Virus, Ad-36 Blamed For Obesity Epidemic In Australians
11. Its High Time the Australian Government Takes Steps against Diabetes
Post Your Comments:
(Date:7/2/2015)... ... , ... In 2012, Patrick Achebe realized that the gift of poetry was fully in him, ... his first poem, and three years later he was publishing an entire book of poetry. ... the world. "I have always believed that the best way to lift yourself up, is ...
(Date:7/2/2015)... Md. (PRWEB) , ... July 02, 2015 , ... Six ... in his solo cross-country walk to raise awareness and money for the Pulmonary ... expects to arrive at PHA’s headquarters near Washington, D.C. by mid-September. He left Glasgow, ...
(Date:7/2/2015)... ... July 02, 2015 , ... Healthpointe ... the orthopedic and spine surgery team at their Anaheim clinic. Dr. Krishnareddy will ... Along with the spine and spine surgery, Dr. Krishnareddy also specializes in the ...
(Date:7/2/2015)... ... July 02, 2015 , ... Octo Consulting ... to the federal government, has announced they are among nine contractors awarded the ... Support Services (BMOSS) contract not to exceed $250 million. , To achieve ...
(Date:7/2/2015)... ... July 02, 2015 , ... B. E. Smith, the only ... lead a national chief executive officer recruitment for Indiana Blood Center ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
Breaking Medicine News(10 mins):Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Octo Consulting Group Awarded IDIQ Contract for SEC Business Management Support 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3
... Georgia Tech Research Institute (GTRI) have developed a sensor ... to asthma attacks. Worn in the pockets of a ... causes of asthma attacks. , We are investigating whether ... see what was going on environmentally when the attack ...
... The use of regular, long-term aspirin and non-steroidal ... cancer, according to a study published in Gastroenterology ... (AGA) Institute. However, the use of aspirin for chemoprevention ... doses that are higher than recommended over a long ...
... prescription drugs so that the system more closely resembles ... drug use without altering patients out-of-pocket spending, health plan ... RAND Corporation study. , Researchers propose that consumers pay ... a years worth of medicine for each prescription they ...
... need to be monitored closely, study says , , TUESDAY, Jan. ... of patients with kidney or liver cancer also increases the ... Nexavar (sorafenib) need to be carefully monitored and treated, said ... online issue of Lancet Oncology . , Nexavar is ...
... Medicine (IGM) at Johns Hopkins will join other national ... ambitious effort that will involve sequencing the genomes of ... most detailed and medically useful picture to date of ... in creating a map of common DNA variation in ...
... Same-sex couples are just as committed in their ... have studied the quality of adult relationships and ... couples in same-sex relationships are not as committed ... as psychologically healthy. , These results are from ...
Cached Medicine News:Health News:Investigating causes of asthma attacks: New sensor system monitors environmental exposure 2Health News:Regular, long-term aspirin use reduces risk of colorectal cancer 2Health News:Researchers propose consumers buy yearly 'drug licenses' as new way to pay for prescriptions 2Health News:Researchers propose consumers buy yearly 'drug licenses' as new way to pay for prescriptions 3Health News:Liver Cancer Drug Raises Blood Pressure 2Health News:Johns Hopkins to participate in 1000 Genomes Project 2Health News:Equal level of commitment and relationship satisfaction found among gay and heterosexual couples 2Health News:Equal level of commitment and relationship satisfaction found among gay and heterosexual couples 3
(Date:7/2/2015)... and VANCOUVER , July 2, 2015 ... EPI) announced today that its common shares have been approved ... under the symbol "EPIX". ESSA will begin trading ... its listing on the TSX Venture Exchange under the symbol ... the common shares on the NASDAQ, each of the Company,s ...
(Date:7/2/2015)... ResMed Inc. (NYSE: RMD ) today announced ... ended June 30, 2015 results on Thursday, July 30, 2015, ... release with ResMed,s results will be issued after 1:00 p.m. ... to discuss operating results and future outlook. The ... Pacific Time and the live webcast of the call can ...
(Date:7/2/2015)... July 2, 2015  New product launches are critical ... role in educating thought leaders about new products, Medical ... influence how well a new therapy performs at launch. ... research and consulting leader Best Practices, LLC, critical aspects ... focus on are early stage thought leader (TL) interaction, ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2
... MOUNTAIN VIEW, Calif., Jan. 24, 2011 Based on ... (PERS) market, Frost & Sullivan recognizes BeClose with the ... Innovation of the Year for its innovative BeClose System ... (Logo:   http://photos.prnewswire.com/prnh/20081117/FSLOGO ) While PERS ...
... Jan. 24, 2011 PharmAthene, Inc. (NYSE Amex: ... Court of Chancery, which commenced January 3, 2011, in its ... Friday, January 21, 2011. The Company anticipates that post trial ... of the court will be complete by the end of ...
Cached Medicine Technology:Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America 2Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America 3Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America 4PharmAthene Provides Update on Litigation With SIGA Technologies 2
... Thermo Labsystems was designed specifically to combine ... such as the new fast dial system ... help to define this as a new ... interchangeable handle plate offers a custom fit ...
... new Finnpipette Focus from Thermo Labsystems was ... performance. Advanced features such as the ... volume adjustment on microvolumes help to define ... channel pipettes. The new interchangeable handle plate ...
... the range from 2ul to 5000ul. Fills ... design prevents inadvertent volume change. Novel hand ... pipette is autoclavable at 121C(250F). To prevent ... Suitable for one-handed operation. Auto or Normal ...
... The AlphaPette Pipettor is the #1 ... Offers accuracy, comfort, and reliability. Continuously ... volume readout sub-micrometer. Easy interchangeable ejector ... tiny hands. Adjustable rapid pipet tip ...
Medicine Products: